<?xml version="1.0" encoding="UTF-8"?>
<ref id="B105-viruses-12-00571">
 <label>105.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Raymond</surname>
    <given-names>A.D.</given-names>
   </name>
   <name>
    <surname>Diaz</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Chevelon</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Agudelo</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Yndart-Arias</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Ding</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Kaushik</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Jayant</surname>
    <given-names>R.D.</given-names>
   </name>
   <name>
    <surname>Nikkhah-Moshaie</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Roy</surname>
    <given-names>U.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Microglia-derived HIV Nef+ exosome impairment of the blood-brain barrier is treatable by nanomedicine-based delivery of Nef peptides</article-title>
  <source>J. Neurovirol.</source>
  <year>2016</year>
  <volume>22</volume>
  <fpage>129</fpage>
  <lpage>139</lpage>
  <pub-id pub-id-type="doi">10.1007/s13365-015-0397-0</pub-id>
  <pub-id pub-id-type="pmid">26631079</pub-id>
 </element-citation>
</ref>
